Possibilities of non-drug treatment methods in the correction of dyslipidemia and manifestations of individual components of the metabolic syndrome
https://doi.org/10.52727/2078-256X-2024-20-1-24-34
Abstract
Aim of the study was to identify the place of low-intensity electro-pulse therapy with biofeedback when it is included in the rehabilitation complex of patients with abdominal obesity to correct the quality of life and individual components of the metabolic syndrome.
Material and methods. In the conditions of the outpatient diagnostic center of City Clinical Hospital No. 2 of Novosibirsk, 60 men and women with abdominal obesity, arterial hypertension and insulin resistance were examined, divided into 3 groups: 1st (main group, n = 25) in addition for standard therapy received a 15-day course of dynamic electroneurostimulation (DENS) from the Neurodance-PCM device; the 2nd (comparison group 1, n = 20), in addition to the basic complex, received DENS procedures from a placebo device, the 3rd (comparison group 2, n = 15) was treated with the use of only a basic therapeutic complex. The control group included 17 men and women without clinical manifestations from the endocrine and cardiovascular systems. The examination included examinations by an endocrinologist, a nutritionist, anthropometry and bioimpedance, assessment of quality of life parameters.
Results. In group 1 patients, 1 month after the start of rehabilitation, there was a greater tendency than in the comparison groups to decrease the body mass index by 9.0 %, a correction of the percentage content in the body structure of fat mass by 1.4 times (p = 0.029) occurred, preprandial glycemia decreased by 1.4 times (p = 0.043) and the level of triglycerides in the blood serum – by 1.4 times (p = 0.044), the increased concentration of free leptin and resistin decreased (1.2 times, p = 0.039), the content of adiponectin in the blood serum increased by 1.2 times (p = 0.041), the quality of life improved 1 month after the start of rehabilitation according to the components of physical and psychological health, which is not observed in the placebo and standard treatment groups.
Conclusions. The inclusion of DENS from the Neurodance-PCM device in the comprehensive rehabilitation of patients with abdominal obesity can contribute to the correction of anthropometry, bioimpedance, carbohydrate and adipokine metabolism indicators. This makes it possible to recommend the inclusion of low-intensity electro-pulse therapy in complex rehabilitation for the correction of quality of life indicators and individual components of the metabolic syndrome.
Keywords
About the Authors
V. A. DrobyshevRussian Federation
Viktor A. Drobyshev, doctor of medical sciences, professor of the department of hospital therapy and medical rehabilitation
52, Krasny av., Novosibirsk, 630091
L. A. Shpagina
Russian Federation
Lubov A. Shpagina, doctor of medical sciences, professor, head of department of hospital therapy and medical rehabilitation
52, Krasny av., Novosibirsk, 630091
I. I. Logvinenko
Russian Federation
Irina I. Logvinenko, doctor of medical sciences, professor, leading researcher of the laboratory of preventive medicine of the research
Boris Bogatkov str., Novosibirsk, 630089
L. G. Agasarov
Russian Federation
Lev G. Agasarov, doctor of medical sciences, professor, head of department of restorative medicine, rehabilitation and balneology; chief researcher
bld. 2, Trubezkaya str., Moscow, 119048,
32, Novy Arbat str., Moscow, 121099
S. G. Abramovich
Russian Federation
Stanislav G. Abramovich, doctor of medical sciences, professor, head of the department of physical and rehabilitation medicine
100, Ubileny microdistrict, Irkutsk, 664049
E. A. Zaikina
Russian Federation
Ekaterina A. Zaikina, physiotherapist of the department of medical rehabilitation and physiotherapy
44, Dzerzhinsky av., Novosibirsk, 630075
N. P. Kareva
Russian Federation
Nina P. Kareva, doctor of medical sciences, professor of department of hospital therapy and medical rehabilitation
52, Krasny av., Novosibirsk, 630091
References
1. Sergienko I.V., Ansheles A.A. Pathogenesis, diagnosis and treatment of atherosclerosis: practical aspects. Russ. Cardiol. Bull., 2021; 16 (1): 64–72. (In Russ.). doi: 10.17116/Cardiobulletin20211601164
2. Aronov D.M., Bubnova M.G., Drapkina O.M. Atherosclerosis pathogenesis from the perspective of microvascular dysfunction. Cardiovascular Therapy and Prevention, 2021; 20 (7): 3076. (In Russ.). doi: 10.15829/1728-8800-2021-3076
3. Authors/Task Force Members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019; 290: 140–205. doi: 10.1016/j.atherosclerosis.2019.08.014
4. Arkhipova E.V. Metabolic syndrome: pathogenesis, diagnostic criteria and treatment. Bull. of the Buryat State University, 2019; (2): 3–9. (In Russ.). doi: 10.18101/2306-1995-2019-2-3-9
5. Belenkov Yu.N., Privalova E.V., Kaplunova V.Yu., Zektser V.Yu., Vinogradova N.N., Ilgisonis I.S., Shakaryants G.A., Kozhevnikova M.V., Lishuta A.S. Metabolic syndrome: the history of development, the main diagnostic criteria. Rational Pharmaco-ther. Cardiol., 2018; 14 (5): 757–764. (In Russ.). doi: 10.20996/1819-6446-2018-14-5-757-764
6. Eley V.A., Thuzar M., Navarro S., Dodd B.R., Zundert A.A. Obesity, metabolic syndrome, and inflammation: An update for anaesthetists caring for patients with obesity. Anaesthesia Critical Care Pain Medicine, 2021; 40 (6): 100947. doi: 10.1016/j.accpm.2021.100947
7. Lyasnikova M.B., Belyakova N.A., Tsvetkova I.G., Rodionov A.A., Milaya N.O. Risks of metabolic illhealth in alimentary-constitutional obesity. Obesity and Metabolism, 2021; 18 (4): 406–416. (In Russ.). doi: 10.14341/omet12705
8. Mukhamedzhanov E.K., Mizin V.I., Mikhailov A.A. Metabolic syndrome – pathogenesis, prospects for prevention, treatment and rehabilitation. Bull. Physiother. Balneol., 2020; 26 (4): 71–74. (In Russ.). doi: 10.37279/2413-0478-2020-26-4-71-74
9. Bovolini A., Garcia J., Andrade M.A., Duarte J.A. Metabolic syndrome pathophysiology and predisposing factors. Int. J. Sports Med., 2021; 42 (3): 199–214. doi: 10.1055/a-1263-0898
10. Myers J., Kokkinos P., Nyelin E. Physical activity, cardiorespiratory fitness, and the metabolic syndrome. Nutrients, 2019; 11 (7): 1652. doi: 10.3390/nu11071652
11. Fahed G., Aoun L., Bou Zerdan M., Allam S., Bou Zerdan M., Bouferraa Y., Assi H.I. Metabolic syndrome: updates on pathophysiology and management in 2021. Int. J. Mol. Sci., 2022; 23 (2): 786. doi: 10.3390/ijms23020786
12. Peng W.W., Tang Z.Y., Zhang F.R., Li H., Kong Y.Z., Iannetti G.D., Hu L. Neurobiological mechanisms of TENS-induced analgesia. Neuroimage, 2019; (195): 396–408. doi: 10.1016/j.neuroimage.2019.03.077
13. Menezes M.A., Pereira T.A.B., Tavares L.M., Leite B.T.Q., Neto A.G.R., Chaves L.M.S., Lima L.V., da Silva-Grigolleto M.E., DeSantana J.M. Immediate effects of transcutaneous electrical nerve stimulation (TENS) administered during resistance exercise on pain intensity and physical performance of healthy subjects: a randomized clinical trial. Eur. J. Appl. Physiol., 2018; 118 (9): 1941–1958. doi: 10.1007/s00421-018-3919-7
14. Kadochnikova E.Yu., Vlasov A.A., Alekseeva L.I., Dydykina I.G., Ershova O.B., Zaitseva E.M., Korotkova T.A., Popova T.A., Sukhareva M.L., Taskina E.A., Sharapova E.P., Solodovnikov A.G., Lesnyak O.M. The effectiveness of dynamic electroneurostimulation (DENS) in the treatment of osteoarthritis of the knee joints (results of a multicenter randomized study). Osteop. Osteopath., 2016; 19 (2): 107–107. (In Russ.). doi: 10.14341/osteo20162107-107
15. Bazarny V.V., Isaikin A.I., Kosareva O.V., Vlasov A.A. Violation of the immune mechanisms of complicated skeletal injury and their correction by dynamic electroneurostimulation. Bull. Resto-rat. Med., 2013; (3): 67–70. (In Russ.).
16. Mummolo S., Nota A., Tecco S., Caruso S., Marchetti E., Marzo G., Cutilli T. Ultra-lowfrequency transcutaneous electric nerve stimulation (ULF-TENS) in subjects with craniofacial pain: A retrospective study. Cranio, 2020; 38 (6): 396–401. doi: 10.1080/08869634.2018.1526849
Review
For citations:
Drobyshev V.A., Shpagina L.A., Logvinenko I.I., Agasarov L.G., Abramovich S.G., Zaikina E.A., Kareva N.P. Possibilities of non-drug treatment methods in the correction of dyslipidemia and manifestations of individual components of the metabolic syndrome. Ateroscleroz. 2024;20(1):24-34. (In Russ.) https://doi.org/10.52727/2078-256X-2024-20-1-24-34